Healthcare & Life Sciences
Tune Therapeutics
United Statestunetx.com/
Tune Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Tune Therapeutics
Based in the United States, Tune Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Tune Therapeutics develops targeted epigenetic editing technologies that regulate gene expression without altering DNA sequences, enabling novel treatments for chronic and age-related diseases.
Explore Tune Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.